Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Broker tips: Keyword Studios, JTC

(Sharecast News) - Citi stuck to its 'neutral' recommendation for Keywords Studios, telling clients that the risks around generative artificial intelligence struck them as "likely overstated". "For what it is worth, it strikes us that some of the concerns about the long-term risk associated with generative AI - which are oft cited as the factor behind the recent aggressive derating - are likely overstated," they said in a research note sent to clients.

They did however slash their discounted free cash flow-based target price from 3,030p to 2,100p as they fine tuned their valuation model.

The specifics behind that reduction were the higher so-called Beta induced by rising rates and higher share price volatility and an increase in the discount rate from 8.5% to 10.0%.

"That our change in PT is so significant is an apt reminder of how much of KWS's value is in the medium- and long-term growth and that even a small change in discount rate can diminish its NPV."

Analysts at ShoreCap upgraded their recommendation for shares of fund administration services outfit JTC to 'buy' in the wake of recent weakness in the share price.

In a research note sent to clients, they also updated their model to factor in the purchase of South Dakota Trust Company -its largest thus far - and the associated fundraising.

As a result, their estimate of 'fair value' for the shares was upped from 840.0p to 850.0p.

They also sounded a positive note on the SDTC acquisition.

In particular, they noted SDTC's 22-year track record of "consistent" growth, the fact that over 98% of its revenues were recurring from fixed fees, stronger EBITDA margin than JTC and "strong" cash conversion.

Share this article

Related Sharecast Articles

Broker tips: Standard Chartered, IG Group
(Sharecast News) - Citi reiterated its 'neutral' rating on Standard Chartered on Wednesday after the company's investor update a day earlier.
Broker tips: Anglo American, On The Beach
(Sharecast News) - Jefferies reiterated its 'buy' rating on Anglo American on Tuesday after the miner announced an agreement to sell its portfolio of steelmaking coal mines in Australia to private UK mining company Dhilmar for up to $3.9bn in cash.
Broker tips: AstraZeneca, GSK, Oxford Instruments
(Sharecast News) - Analysts at Citi have reiterated a 'buy' rating on AstraZeneca and a 'neutral' on GSK following the European pharma sector's first-quarter earnings season.
Broker tips: Aegon, Standard Life, Aberdeen, Card Factory
(Sharecast News) - JPMorgan reiterated its 'overweight' stance on Aegon on Friday and double-upgraded Standard Life as it said the sale of Aegon UK to Standard Life is highly likely to receive regulatory approval, which would be "very positive for both".

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.